Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Industry News

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

November 03, 2016

News Conference News ESC 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Michael O'Riordan

August 30, 2016

News Daily News

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Yael L. Maxwell

July 27, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Industry News

Biotronik launches 2 new studies

August 13, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Industry News

DC Devices Completes Enrollment In Clinical Trial Of The First Transcatheter Device To Treat Diastolic Heart Failure; Announces Name Change To Corvia Medical

June 22, 2015

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

April 21, 2014

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

Advertisement

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

Biotronik launches 2 new studies

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

DC Devices Completes Enrollment In Clinical Trial Of The First Transcatheter Device To Treat Diastolic Heart Failure; Announces Name Change To Corvia Medical

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content